Latest Reported Offering
$50,000
Target Amount
$5,000,000
Maximum Amount
2024-04-29
Deadline
Security Details
Type: Common Stock
Price per share: $0.10
Price set by: Dividing pre-money valuation $128,210,743.7 (or $115,389,669.33 for investors in the first $3,000,000.06) by number of shares outstanding on fully diluted basis.
Shares offered: 555,556+
Offering Costs
Cash commission: 6.5%
of the offering amount upon a successful fundraise, and be entitled to reimbursement for out-of-pocket third party expenses it pays or incurs on behalf of the Issuer in connection with the offering.
Equity compensation: —
No
Filing history
Form C family — 2 filingsThe reported figures behind Psycheceutical Bioscience, Inc.
Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.
- Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
- A sparkline on each figure so the shape is visible before the numbers
- A revenue series dated to the filings that reported it
- The campaign as filed: target, ceiling, deadline, and the portal that ran it
- Follow it, and see it change on your watchlist
Company Information
Legal Status
Corporation
Jurisdiction
NV
Date of Incorporation
2004-06-16
Latest Metrics
Employees4
Total Assets$2,374,077
Cash on Hand$1,994,805
Revenues$0.00
Net Income-$16,979,840
Crowdfunding Portals
The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.